In terms of autoantibodies, 76 (80.0%) RA patients were positive for rheumatoid factor (RF) and 56 (58.9%) RA patients were positive for anti-cyclic citrullinated peptide antibody (ACPA). This evidence concerns the gene PRTN3 and rheumatoid arthritis.